Description

Imidazo[1,2-A]Pyrazine-6-Carboxamide, n-2-Azabicyclo[2.2.1]Hept-6-Yl- (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure. This compound is of significant value in medicinal chemistry for its role as a key building block in the synthesis of novel therapeutic agents. It is primarily sought by research institutions and pharmaceutical companies engaged in the development of new drugs, particularly within the fields of oncology and central nervous system (CNS) disorders.

Application

• Pharmaceutical Intermediate: A critical precursor in the research and synthesis of novel active pharmaceutical ingredients (APIs) targeting specific biological pathways.
• Medicinal Chemistry Research: Serves as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Oncology Drug Development: Used in the construction of potential kinase inhibitors and other targeted cancer therapies due to its imidazopyrazine core.
• CNS-Active Compound Synthesis: Employed in the development of potential therapeutics for neurological and psychiatric conditions.
• Chemical Biology Probes: Utilized as a building block for creating molecular probes to study enzyme function and cellular processes.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up of complex molecules for clinical trials.

Basic Information

Product Name	Imidazo[1,2-A]Pyrazine-6-Carboxamide, n-2-Azabicyclo[2.2.1]Hept-6-Yl- (9Ci)
CAS No.	588725-89-7
Molecular Formula	C13H15N5O
Molecular Weight	257.29 g/mol
Synonyms	N-(2-Azabicyclo[2.2.1]hept-6-yl)imidazo[1,2-a]pyrazine-6-carboxamide; 2-Azabicyclo[2.2.1]hept-6-amine, N-(imidazo[1,2-a]pyrazin-6-ylcarbonyl)-; Imidazo[1,2-a]pyrazine-6-carboxamide, N-(2-azabicyclo[2.2.1]hept-6-yl)-; 588725-89-7; (1S,4R)-N-(2-Azabicyclo[2.2.1]hept-6-yl)imidazo[1,2-a]pyrazine-6-carboxamide (potential stereoisomer); Endo-N-(2-Azabicyclo[2.2.1]hept-6-yl)imidazo[1,2-a]pyrazine-6-carboxamide
EINECS	Contact for details

Quality Control

Our Imidazo[1,2-A]Pyrazine-6-Carboxamide intermediate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the exacting standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and analytical methods is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The material may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.